Sabine Kayser (Mannheim / DE), Richard F. Schlenk (Heidelberg / DE), Stefan A. Klein (Mannheim / DE), Daniela Heidenreich (Mannheim / DE), Martin Hoffmann (Ludwigshafen / DE), Peter Paschka (Ludwigshafen / DE), Marcus Steiner (Mannheim / DE), Harald Klüter (Mannheim / DE), Patrick Wuchter (Mannheim / DE)
Autologous stem cell collection (ASCC) from the peripheral blood after mobilization with granulocyte-colony stimulating factor (G-CSF) remains an important option for patients with hemato-oncological diseases as part of initial therapy or at relapsed/refractory stage. We aimed to identify factors predictive of successful CD34+ ASCC.
We retrospectively evaluated 255 patients who underwent an ASCC (median age 60.5 years, range 7.5-74 years) at our institution from 2017 to 2023. The predicted minimal number of CD34+ cells to be collected was calculated as follows: [(peripheral CD34+ cells/µL) × adjusted collection efficiency of 30%] × total liters processed per kg body weight (bw).
229 patients had hematological diseases (multiple myeloma (MM), n=115; non-Hodgkin"s lymphoma (NHL), n=102; Hodgkin's lymphoma (HL), n=11; amyloidosis, n=1), 15 patients had germ-line tumors, 8 had Ewing"s sarcoma, and 3 had multiple sclerosis. 159 patients were of male gender.
Overall, 333 ASCC were performed. In 78 patients (31%) more than 1 apheresis session was necessary to reach the collection goal (range 2-4). In addition to G-CSF, the CXCR4-antagonist plerixafor was given in 24 patients (9%) (MM and NHL, n=9, each; germ-line tumor, n=3; HL, n=2; Ewing"s sarcoma, n=1).
Total CD34+ collection was in median 6.6 × 106 CD34+ cells/kg bw (range, 0.2-62.7), 3.5 × 106 CD34+ cells/kg bw (range, 0.6-14.4), 3.2 × 106 CD34+ cells/kg bw (range, 0.3-6.7) and 5.2 × 106 CD34+ cells/kg bw (range, 2.1-8.4) on the 1st, 2nd, 3rd and 4th apheresis session, respectively.
Predictive factors for a higher CD34+ cell collection at first apheresis were male sex (p = 0.003) as well as CD34+ cell count/µl in peripheral blood (p < 0.0001). White blood cell count, platelets, hemoglobin, and age had no significant predictive value. Predicted versus observed number of CD34+ cells/kg bw collected demonstrated a very strong linear correlation (r = 0.93, p < 0.0001).
Of the routinely monitored indicators in ASCC, male sex and CD34+ cell count in peripheral blood were predictive factors of the collection yield. The CD34+ cell count was used to prospectively calculate the minimal number of collected CD34+ cells in order to determine the necessary duration of the individual apheresis session.
Nothing to disclose.
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.